Biopreservation Market Size, Share, Opportunities, And Trends By Products (Biopreservation Media, Equipment), By Application (Biobanking, Regenerative Medicine, Drug Discovery, Others), By End-Users (Biobanks, Hospitals, Other Application Areas), And By Geography - Forecasts From 2024 To 2029

  • Published : Feb 2024
  • Report Code : KSI061616630
  • Pages : 140

The biopreservation market is anticipated to grow at a steady pace during the projected period.

Biopreservation is a critical process in the field of life sciences and healthcare that involves the storage and preservation of biological materials, such as cells, tissues, and organs, to maintain their viability, functionality, and integrity for extended periods. The goal of biopreservation is to prevent cellular damage and degradation, allowing these biological specimens to be stored for future use in research, diagnostics, and therapeutic applications. Various techniques are employed in biopreservation, including cryopreservation, which involves freezing biological samples at extremely low temperatures, and vitrification, a process that avoids ice formation during preservation. These methods are crucial in regenerative medicine, where preserved cells and tissues may be used for transplantation or tissue engineering.

Biopreservation plays a pivotal role in supporting advancements in medical research, drug development, and personalized medicine. It enables the establishment of biobanks and repositories of well-preserved biological materials, facilitating collaborative research and the development of novel therapies. As the understanding of biopreservation techniques evolves, the field continues to contribute significantly to scientific breakthroughs and innovations in the broader healthcare landscape.

Market Drivers

  • Increasing healthcare expenditure

The rising healthcare expenditure significantly impacts the biopreservation market in several ways. As healthcare spending increases, there is a growing emphasis on advanced medical technologies and services, including biopreservation solutions. Biopreservation plays a crucial role in the storage and preservation of biological samples, tissues, and cells for various applications in research, diagnostics, and therapeutic development. With higher healthcare budgets, research institutions, biotechnology companies, and healthcare facilities are more likely to invest in state-of-the-art biopreservation technologies and services. This includes the adoption of innovative preservation methods, advanced storage facilities, and quality control measures to ensure the integrity of biological materials over extended periods. In 2021, healthcare expenditures in the United States witnessed a growth of 2.7%, reaching a staggering $4.3 trillion, equivalent to $12,914 per capita. This notable increase underscores the continued upward trend in healthcare spending, reflecting the substantial financial commitment dedicated to maintaining and improving the nation's healthcare system.

  • Use in regenerative medicine

Regenerative medicines play a crucial role in repairing, replacing, and regenerating tissues and organs impacted by injury, disease, or the natural aging process. These therapeutic interventions aim to restore cellular and tissue functionality and find applications in addressing various degenerative disorders, including dermatological conditions, neurodegenerative diseases, cardiovascular issues, and orthopedic concerns. The growth of this sector is anticipated to be driven by global collaborations and partnerships focused on advancing research and development in regenerative medicine. An illustrative example is the initiation of the Regenerative Medicine Catalyst Project in September 2021, involving seven collaborative partners working together to monitor and enhance regenerative medicine research and funding over the next three years. Additionally, the escalating demand for regenerative medicine, incorporating biopreservation techniques for the treatment of life-threatening ailments like cancer, is poised to further propel the growth of this segment.

North America is anticipated to hold a significant share of the market-

The North American market experiences significant impetus driven by a heightened demand for preserving various biological specimens, including blood, solid tissue specimens such as paraffin-embedded or frozen bio-specimens of tumors, and other tissues like peripheral blood cells, bone marrow, and stem cells-derived cord blood and its derivatives. This demand is observed across multiple research institutes, pathological centers, and hospitals in the region. The surge in government investments, particularly in drug discovery initiatives, is expected to enhance the utilization of biopreservation for preserving cells, tissues, and organs ex-vivo, facilitating their storage, shipment, and transportation. Notably, the Canadian government has allocated a substantial investment of USD 45 million in the current year, spanning the next three years, to the Stem Cell Network, aimed at promoting stem cell and regenerative medicine research. Such strategic investments are poised to elevate the utility and demand for biopreservation in the region, thereby fostering market growth throughout the forecast period.

Market Developments

  • In February 2022, OriGen Biomedical Inc., a worldwide medical device manufacturer specializing in cryopreservation, cell culture, and respiratory products, introduced the CryoStore FLEX Freezing Bag in both the United States and Europe. Specifically crafted for the cryopreservation of blood components, this innovative CryoStore FLEX Bag provides the versatility of multi-chamber flexibility for small-volume dose solutions.
  • In October 2022, Azenta, Inc. completed the acquisition of B Medical Systems S.á r.l and its subsidiaries. B Medical Systems is recognized for offering temperature-controlled storage and transportation solutions, facilitating the global delivery of life-saving treatments.

Market Segmentation

  • By Products
    • Biopreservation Media
    • Equipment
  • By Application
    • Biobanking
    • Regenerative Medicine
    • Drug Discovery
    • Others
  • By End-Users
    • Biobanks
    • Hospitals
    • Other Application Areas
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Taiwan
      • Thailand
      • Indonesia
      • Others

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings

3.2. Analyst View

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Russia-Ukraine War Impact Analysis

5. BIOPRESERVATION MARKET BY PRODUCTS

5.1. Introduction

5.2. Biopreservation Media

5.2.1. Market Trends and Opportunities

5.2.2. Growth Prospects

5.3. Equipment

5.3.1. Market Trends and Opportunities 

5.3.2. Growth Prospects

5.3.3. Temperature Maintaining Units

5.3.4. Consumables

5.3.5. Other Equipment

6. BIOPRESERVATION MARKET BY APPLICATION 

6.1. Introduction

6.2. Biobanking

6.2.1. Market Trends and Opportunities

6.2.2. Growth Prospects

6.3. Regenerative Medicine

6.3.1. Market Trends and Opportunities

6.3.2. Growth Prospects

6.4. Drug Discovery

6.4.1. Market Trends and Opportunities

6.4.2. Growth Prospects

6.5. Other Application Areas

6.5.1. Market Trends and Opportunities

6.5.2. Growth Prospects

7. BIOPRESERVATION MARKET BY END-USER

7.1. Introduction

7.2. Biobanks

7.2.1. Market Trends and Opportunities

7.2.2. Growth Prospects

7.3. Hospitals

7.3.1. Market Trends and Opportunities

7.3.2. Growth Prospects

7.4. Others

7.4.1. Market Trends and Opportunities

7.4.2. Growth Prospects

8. BIOPRESERVATION MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. By Products

8.2.2. By Application

8.2.3. By End-User

8.2.4. By Country

8.2.4.1. United States

8.2.4.1.1. Market Trends and Opportunities

8.2.4.1.2. Growth Prospects

8.2.4.2. Canada

8.2.4.2.1. Market Trends and Opportunities

8.2.4.2.2. Growth Prospects

8.2.4.3. Mexico

8.2.4.3.1. Market Trends and Opportunities

8.2.4.3.2. Growth Prospects

8.3. South America

8.3.1. By Products

8.3.2. By Application

8.3.3. By End-User

8.3.4. By Country 

8.3.4.1. Brazil

8.3.4.1.1. Market Trends and Opportunities

8.3.4.1.2. Growth Prospects

8.3.4.2. Argentina

8.3.4.2.1. Market Trends and Opportunities

8.3.4.2.2. Growth Prospects

8.3.4.3. Others

8.3.4.3.1. Market Trends and Opportunities

8.3.4.3.2. Growth Prospects

8.4. Europe

8.4.1. By Products

8.4.2. By Application

8.4.3. By End-User

8.4.4. By Country

8.4.4.1. United Kingdom

8.4.4.1.1. Market Trends and Opportunities

8.4.4.1.2. Growth Prospects

8.4.4.2. Germany

8.4.4.2.1. Market Trends and Opportunities

8.4.4.2.2. Growth Prospects

8.4.4.3. France

8.4.4.3.1. Market Trends and Opportunities

8.4.4.3.2. Growth Prospects

8.4.4.4. Italy

8.4.4.4.1. Market Trends and Opportunities

8.4.4.4.2. Growth Prospects

8.4.4.5. Spain

8.4.4.5.1. Market Trends and Opportunities

8.4.4.5.2. Growth Prospects

8.4.4.6. Others

8.4.4.6.1. Market Trends and Opportunities

8.4.4.6.2. Growth Prospects

8.5. Middle East and Africa

8.5.1. By Products

8.5.2. By Application

8.5.3. By End-User

8.5.4. By Country

8.5.4.1. Saudi Arabia

8.5.4.1.1. Market Trends and Opportunities

8.5.4.1.2. Growth Prospects

8.5.4.2. UAE

8.5.4.2.1. Market Trends and Opportunities

8.5.4.2.2. Growth Prospects

8.5.4.3. Others

8.5.4.3.1. Market Trends and Opportunities

8.5.4.3.2. Growth Prospects

8.6. Asia Pacific

8.6.1. By Products

8.6.2. By Application

8.6.3. By End-User

8.6.4. By Country

8.6.5. Japan

8.6.5.1.1. Market Trends and Opportunities

8.6.5.1.2. Growth Prospects

8.6.6. China

8.6.6.1.1. Market Trends and Opportunities

8.6.6.1.2. Growth Prospects

8.6.7. India

8.6.7.1.1. Market Trends and Opportunities

8.6.7.1.2. Growth Prospects

8.6.8. South Korea

8.6.8.1.1. Market Trends and Opportunities

8.6.8.1.2. Growth Prospects

8.6.9. Taiwan

8.6.9.1.1. Market Trends and Opportunities

8.6.9.1.2. Growth Prospects

8.6.10. Thailand

8.6.10.1.1. Market Trends and Opportunities

8.6.10.1.2. Growth Prospects

8.6.11. Indonesia

8.6.11.1.1. Market Trends and Opportunities

8.6.11.1.2. Growth Prospects

8.6.12. Others

8.6.12.1.1. Market Trends and Opportunities

8.6.12.1.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. BioCision LLC

10.2. BioLife Solutions Inc.

10.3. Cesca Therapeutics Inc.

10.4. Lifeline Scientific Inc.

10.5. Merck KGaA

10.6. Princeton CryoTech Inc.

10.7. VWR International

10.8. Azenta US Inc. 

10.9. Thermo Fisher Scientific Inc

10.10. MVE Biological Solutions 


BioCision LLC

BioLife Solutions Inc.

Cesca Therapeutics Inc.

Lifeline Scientific Inc.

Merck KGaA

Princeton CryoTech Inc.

VWR International

Azenta US Inc. 

Thermo Fisher Scientific Inc

MVE Biological Solutions